|
SUGGESTED USE: As a dietary supplement, take
9 tablets daily in divided doses 30-60 minutes before
each meal.
RECOMPOSIZE™ is an exclusive formula that includes
Super CitriMax® Clinical Strength and Synaptamine™,
patent pending, patented, and trademarked ingredients,
designed to promote healthy fat loss and achieve weight
management goals.* Super CitriMax® Clinical Strength
is a patent pending weight control formula containing
optimal doses of Super CitriMax® (-) hydroxycitric acid
and ChromeMate® oxygen-coordinated niacin-bound chromium,
which have been clinically tested to: Reduce body
weight, Curb appetite, Promote healthy serotonin levels,
Promote fat burning, Reduce body mass index and Maintain
healthy cholesterol & blood lipid levels.*
Super CitriMax® is a patent-pending form
of (-) hydroxycitric acid (HCA) bound to calcium and
potassium, which contains 20% more HCA and is significantly
more bioavailable than ordinary calcium-based HCA ingredients.
Synaptamine is a patented complex of nutrients
and botanicals, which has been clinically shown, both
individually and in combination, to: Curb cravings,
Reduce the effects of stress, Promote healthy endorphin
function, Promote healthy dopamine function, Promote
healthy brain function, and Promote healthy weight management.*
For optimal results, Recomposize should be taken
in combination with a healthy diet and exercise regimen.
* These statements have not been evaluated by the
Food and Drug Administration. This product is not intended
to diagnose, treat, cure, or prevent any disease.
This proprietary formula is manufactured
exclusively for and distributed by Health Thru Nutrition
|
|
ChromeMate® brand oxygen-coordinated
niacin-bound chromium (U.S. Patents 4,923,855, 4,954,492
and 5,194,615) and Super CitriMax®
Clinical Strength are trademarks of InterHealth N.I.
SYNAPTAMINE (U.S. Patent
6,132,724, other U.S. and PCT Patents Pending) is a
trademark of Synaptamine, Inc.
§ Emed-PF is a trademark
of Euromed USA.
All materials are certified and all
products manufactured in accordance with the Current
Good Manufacturing Practices as prescribed by the Food
and Drug Administration of the United States (CFR21).
|